|
Malaria epidemiology, surveillance and response
|
Mapping of mobile migrant populations (MMPs) (malaria burden in MMPs; Information on MMP status for every case in the MIS; prophylaxis for malaria control in MMP)
|
|
Improved case surveillance (case-based surveillance with GIS (low endemic settings); detailed malaria risk maps; Real time cross-border surveillance to be used by both the countries; follow up surveillance for directly observed therapy (DOT) adherence)
|
|
Malaria case management
|
Asymptomatic cases and active surveillance and treatment
|
|
Feasibility of conducting DOTs for malaria cases
|
|
Use of microscopy as a primary method of laboratory confirmed diagnosis for malaria and establishment of a quality control program
|
|
Control of malaria vectors
|
Vector Mapping—Changing environment/Epidemiology/variation across the country requires research into vectors (changing biting patters, life-cycle, species, exo/endophilic, etc.)
|
|
Insecticide resistance: research into potential pyrethroid resistance/insecticide efficacy
|
|
Bed net research—Good national coverage, but how effective are they, are they protecting the most at risk populations (mobile migrant workers); Sleeping behaviour of the net use net preference studies (hammocks, texture, colour)
|
|
Malaria behavioural issues
|
How Does DOT change behaviour of the patients? Adherence of DOTs
|
|
Huge investments in DOTs—are they worth it?
|
|
How can we increase participatory village interventions? Active community involvement?
|
|
How can we increase the malaria education provided to patients by health facilities/village malaria workers (VMW)?
|
|
How best to communicate with MMPs/forest goers?
|
|
Malaria clinical studies
|
New ACTs drug efficacy, Artesunate + Pyronaridine
|
|
First line treatment drug efficacy (Pf, Pv)
|
|
Safety of primaquine (G6PD Screening)
|
|
Other vector borne diseases (Dengue, NTDs and STHs)
|
Dengue/chikungunya surveillance and estimation of disease burden—lacking in adult and private sector
|
|
To determine a sustainable, effective and ecologically safe vector control measure for dengue control
|
|
NTD surveillance and estimation of disease burden—lacking in private sector
|
|
NTD surveillance and vector control
|
